[1]
Virú-Loza, M.A. 2021. Lack of benefit from combined therapy with gonadotropin-releasing hormone analog (GnRHa) and recombinant human growth hormone (rhGH) in patients with early or precocious puberty. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo. 14, 1 (Jun. 2021), 100–102. DOI:https://doi.org/10.35434/rcmhnaaa.2021.141.907.